The World Health Organization issued new guidelines Monday recommending the use of GLP-1 drugs for treating obesity.

In the new guidelines , the United Nations health agency made two key recommendations — first, that GLP-1 therapies may be used by adults for long-term treatment of obesity, except for pregnant women. It also recommended intensive behavioral therapy, including changes related to diet and exercise, alongside the use of the medications.

"Obesity is a major global health challenge that WHO is committed to addressing by supporting countries and people worldwide to control it, effectively and equitably. Our new guidance recognizes that obesity is a chronic disease that can be treated with comprehensive and lifelong care," Dr. Tedros Adhanom Ghebreyesus, director-general of

See Full Page